Rufinamide in patients with Lennox-Gastaut syndrome
Peggy O Clark,1 Patricia A Gibson2 1Cincinnati Children’s Hospital Medical Center, The University of Cincinnati College of Medicine, Cincinnati, OH, 2Epilepsy Information Service, Wake Forest University School of Medicine, Winston-Salem, NC, USA Objectives: Lennox–Gastaut syndrom...
Guardado en:
Autores principales: | Clark PO, Gibson PA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4ec29a4b19764cf380443c5654fcfd2c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Adjunctive Rufinamide in Children with Lennox-Gastaut Syndrome: A Literature Review
por: Balagura G, et al.
Publicado: (2020) -
Truncating mutation in TANC2 in a Chinese boy associated with Lennox-Gastaut syndrome: a case report
por: Yang Tian, et al.
Publicado: (2021) -
Case Report: Lennox–Gastaut Epileptic Encephalopathy Responsive to Cannabidiol Treatment Associated With a Novel de novo Mosaic SHANK1 Variant
por: Justyna Paprocka, et al.
Publicado: (2021) -
Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions
por: Ostendorf AP, et al.
Publicado: (2017) -
Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide
por: Carl E Stafstrom
Publicado: (2009)